Non-healing chronic wounds can have a significant negative impact on a patient’s quality of life as well as placing additional demands on NHS resources. Balancing health economics with optimal clinical outcomes for patients is a daily challenge for wound care specialists. Studies and case reports have demonstrated that wound care products that contain octenidine are both clinically and cost-effective when managing chronic wounds.